跳至主要内容
临床试验/ISRCTN51513145
ISRCTN51513145已完成未知

A randomised controlled pilot study comparing standard fluid management with haemoconcentration of remaining cardiopulmonary bypass blood using the new Hemosep device

Papworth Hospital NHS Trust (UK)0 个研究点目标入组 60 人开始时间: 2014年2月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Adult patients undergoing elective or urgent coronary artery bypass graft surgery (CABG), heart valve surgery, or a combination of CABG and valve surgery will be included.; Target Gender: Male & Female ; Lower Age Limit 18 years

排除标准

  • 1. Patients under 18 years of age
  • 2. Patients undergoing emergency surgery
  • 3. Patients with a contraindication to either heparin, protamine or tranexamic acid
  • 4. Patients who might not adequately understand verbal explanations or written information given in English, or who have special communication needs

研究者

发起方
Papworth Hospital NHS Trust (UK)

相似试验